Disparities Details by Sex for 2012
IID-7.2 : Children receiving 3+ or 4+ doses of Hib vaccine by age 19–35 months (percent)
This chart compares rates by population.
Error Bar (I) represents the 95% confidence interval.
Additional footnotes may apply to these data. Please refer to footnotes below the data table for further information.
See also Disparities Overview by Sex for IID-7.2
IID-7.2 Achieve and maintain an effective vaccination coverage level of 3 or 4 doses of Haemophilus influenzae type b (Hib) vaccine among children by age 19 to 35 months
Children receiving 3+ or 4+ doses of Hib vaccine by age 19–35 months (percent)
1 Baseline has been revised. See Data Details for more information.
Data are subject to revision and may have changed since a previous release.
Unless noted otherwise, any age-adjusted data are adjusted using the year 2000 standard population.
Data are not available or not collected for populations not shown.
CI: 95% confidence interval.
- The better group rate for this objective, 81.6%, was attained by the male population.
- The worse group rate for this objective, 80.2%, was attained by the female population.
- The absolute difference (or range) between the best and worst group rates was 1.5 percentage points.
- The best group rate was <1.100 times the worst group rate.
The male population achieved the better group rate for this objective, 81.6%.
The better group rate was <1.1 times the rate for the female population.